Switching Between Semaglutide and Tirzepatide

People switch for three reasons: results have stalled, side effects are intolerable, or cost or supply changed. All three are legitimate, and switching is standard practice rather than an admission that something went wrong.

Semaglutide and tirzepatide are not the same drug

This is the part that matters for switching.

Semaglutide activates one receptor: GLP-1. Tirzepatide activates two: GLP-1 and GIP.

Because the mechanisms differ, so does the dosing, and there is no reliable milligram-for-milligram conversion. Semaglutide tops out at 2.4 mg weekly for weight management; tirzepatide runs to 15 mg. The numbers are not comparable, and anyone offering you a conversion table is guessing.

Trial mean weight loss sits around 15 to 17.5% for semaglutide and roughly 20.9 to 22.5% for tirzepatide, though these come from separate studies rather than a head-to-head trial.

Do you restart at the lowest dose?

Usually yes, or close to it. Your prescriber decides, and the reasoning is straightforward: the GIP receptor is new territory for your body even if GLP-1 is not.

Some prescribers start slightly higher for patients already tolerating a high semaglutide dose. That is a clinical judgement based on your history, not a rule you can apply yourself.

Practically, this means the first two to three months after switching involve re-escalation, and effect may dip during that period. It is temporary and expected.

How long to wait between

The usual approach is to start the new medication on the day your next dose of the old one would have been due — typically about a week.

Both drugs are weekly with long half-lives, so there is overlap in your system regardless. Longer gaps risk appetite returning and some weight regain. Your prescriber sets the specific interval.

Semaglutide to tirzepatide

The more common direction, usually for better results.

What to expect: a re-escalation over roughly 16 to 20 weeks. Side effects during that ramp, similar to your original start. Better appetite suppression than semaglutide for most people once you reach a comparable dose.

Watch for: assuming your semaglutide tolerance transfers. Some people who handled 2.4 mg semaglutide comfortably find tirzepatide’s escalation harder, because the GIP component is genuinely different.

Tirzepatide to semaglutide

Less common, and the reasons are usually cost, supply, or side effects.

What to expect: possibly less appetite suppression, since semaglutide’s ceiling is lower in trials. Some people tolerate it better. Insurance coverage is sometimes easier for Wegovy than Zepbound depending on the plan.

Watch for: disappointment if you expected equivalence. If tirzepatide was working and you are switching for cost, check every route first — our cheapest semaglutide guide and tirzepatide cost breakdown cover options most people never look at.

Will I regain weight during the switch?

Some, possibly, during the low-dose period. It is usually modest and recovers as you escalate.

Things that reduce the dip: keeping the gap short, maintaining protein intake, and not treating the transition as a break from everything else you were doing.

When switching is not the answer

You have not reached the maintenance dose. Switching at week 8 because results are slow means abandoning a drug that has not yet reached its working dose. See our dosing schedule.

You are at a plateau after significant loss. A plateau at month eight after losing 15% is often the body reaching equilibrium, not the drug failing.

Side effects during escalation. Holding the current dose for another four weeks solves this more often than switching does.

Educational information, not medical advice. Switching medications, dosing, and timing are decisions for you and a licensed clinician.